Glibornuride: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{chembox | |||
| Verifiedfields = changed | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
{{ | | UNII = VP83E7434R | ||
| verifiedrevid = 444003955 | |||
|ImageFile=Glibornuride02.png | |||
|ImageSize=200px | |||
|IUPACName=1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea | |||
|OtherNames= | |||
|Section1={{Chembox Identifiers | |||
| CASNo_Ref = {{cascite|correct|??}} | |||
| CASNo=26944-48-9 | |||
| PubChem=33649 | |||
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} | |||
| DrugBank = DB08962 | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D02427 | |||
| SMILES=CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2C3CCC(C2O)(C3(C)C)C | |||
| ATCCode_prefix = A10 | |||
| ATCCode_suffix = BB04 | |||
}} | |||
|Section2={{Chembox Properties | |||
| Formula=C<sub>18</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>S | |||
| MolarMass=366.48 g/mol | |||
| Appearance= | |||
| Density= | |||
| MeltingPt= | |||
| BoilingPt= | |||
| Solubility= | |||
}} | |||
|Section3={{Chembox Hazards | |||
| MainHazards= | |||
| FlashPt= | |||
| Autoignition= | |||
}} | |||
}} | |||
==Overview== | ==Overview== |
Revision as of 20:54, 6 April 2015
Template:Chembox E number
Names | |
---|---|
IUPAC name
1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
| |
Identifiers | |
3D model (JSmol)
|
|
DrugBank | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
KEGG | |
PubChem CID
|
|
| |
Properties | |
C18H26N2O4S | |
Molar mass | 366.48 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Overview
Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]
References
- ↑ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.
Categories:
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Articles without InChI source
- Chemical pages without ChemSpiderID
- Articles without EBI source
- Articles without UNII source
- Chemical articles with unknown parameter in Chembox
- Articles with changed DrugBank identifier
- ECHA InfoCard ID from Wikidata
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Alcohols
- Drug
- Sulfonylureas